• Board of Directors

    • Thomas Staab, BioCryst Pharmaceuticals, Board Chairman
    • Jeff Abbey, Argos Therapeutics
    • Peyton Anderson, Affinergy
    • Lynn Bottone, Pfizer
    • Dennis Burns, TCG Group
    • Christopher Capel, Smith Anderson
    • Joe Cascone, Mayne Pharma
    • David Chapin, Forma Life Science Marketing
    • Jeff Collins, Pappas Ventures
    • Terry Costello, Royal Hill Consulting
    • Jay Dixon, PPD
    • Michelle Douglas, Ketchum
    • Bill Edwards, Merz North America
    • Mike Elder, Novozymes
    • Tom Fagley, Hughes Pittman & Gupton
    • Ed Field, E. BioConsulting
    • Neal Fowler, Liquidia Technologies
    • Amy Fullbright, K&L Gates
    • Shawn Gallagher, Eisai
    • Maeve Gardner, GSK
    • Christof Jensen, UCB
    • Matt Keffer, PricewaterhouseCoopers
    • Scott Kohne, Bayer
    • William Lee, Cato Bioventures
    • Susan Lillard Thomason, QuintilesIMS
    • Mike McBrierty, Biogen
    • Martin Meeson, Fujifilm Diosynth Biotechnologies
    • Russ Read, National Center for Biotechnology Workforce
    • Scott Sewell, Cook Medical
    • Oliver Sherrill, Alexandria Real Estate Equities
    • Giles Shih, BioResource International
    • Gary Shope, Patheon
    • Brad Walters, RTI International
    • Eric Ward, AgBiome
    • Rich West, Baebies
    • Tim Willis, MED1 Ventures 
    • Adam Zerda, BD Technologies

    ‚Äč

  • Mark Your Calendar

     
  • Latest Tweets